Uehara Y, Ikegami M, Kohsaka S, Kimura H, et al. Real-world clinical characteristics and outcomes in patients with HER2-mutant non-small cell lung cancer (NSCLC) who received second-line treatment: A nationwide database analysis in Japan. Lung Cancer 2026;218:109491.
PMID: 42263332